Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

View source ↗

Summary

Clinical trial update describing a longitudinal biomarker study to determine whether TTR-stabilizing therapy affects circulating TTR amyloid aggregates in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Transthyretin (TTR) Amyloid Cardiomyopathy | Status: RECRUITING